E
Elliott M. Antman
Researcher at Brigham and Women's Hospital
Publications - 738
Citations - 187175
Elliott M. Antman is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 161, co-authored 716 publications receiving 179462 citations. Previous affiliations of Elliott M. Antman include Duke University & Katholieke Universiteit Leuven.
Papers
More filters
Journal ArticleDOI
Comparison of effects of propranolol versus pindolol on sinus rate and pacing frequency in sick sinus syndrome
S. Adam Strickberger,R. David Fish,Gervasio A. Lamas,Catherine Cantillon,Satinder J.S. Bhatia,Noreen McGowan,Elliott M. Antman,Peter L. Friedman +7 more
TL;DR: Beta blockers like pindolol, which cause less sinus node depression, may obviate the need for prophylactic permanent pacemakers in patients with SSS, and may help to prevent chronotropic incompetence and pacemaker syndrome in patients already treated with a VVI device.
Journal ArticleDOI
Issues in early risk stratification for UA/NSTEMI
TL;DR: Although many were encouraged by the data on C-reactive protein (CRP) as a prognostic indicator, it was generally agreed that it is too soon to recommend its routine measurement in ACS.
Journal ArticleDOI
Evidence and Education
TL;DR: The legacy of Dr Herrick is used as a lens to assess the evolution of how the authors acquire evidence and organize their educational mission, based on the 2010 Herrick Lecture.
Journal ArticleDOI
The re-emergence of anticoagulation in coronary disease
TL;DR: Ximelagatran, the first in this class of agents, has the potential to overcome the limitations of existing antithrombotic therapies and is currently undergoing extensive clinical evaluation in a range of indications, including ACS.
Journal ArticleDOI
Omega-3 Fatty Acids Effect on Post-Myocardial Infarction ST2 Levels for Heart Failure and Myocardial Fibrosis.
Bobak Heydari,Shuaib M Abdullah,Ravi V. Shah,Sanjeev A. Francis,Jiazhuo H. Feng,Joseph P. McConnell,William H. Harris,Elliott M. Antman,Michael Jerosch-Herold,Raymond Y. Kwong +9 more
TL;DR: A trial of patients with acute myocardial infarction reported significant attenuation of adverse left ventricular remodeling and noninfarct myocardIAL fibrosis after 6 months.